| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
NEW YORK—In trying to reach the $1000 genome, sequencing-by-synthesis (SBS) methods have gained in popularity; however, like most sequencing experiments, SBS requires scientists to perform four separate reactions for each of the nucleotides. Recently, researchers at Columbia University have addressed this problem by developing fluorescently tagged nucleotides that allow them to sequence DNA in a single reaction.
 
As reported in PNAS, the researchers synthesized four terminator nucleotide analogues modified at the 3′ OH with an allyl blocking group and at the 5-position (pyrimidines) or 7-position (purines) with allyl-fluorophore tags based on Bodipy or rhodamine. Because each tag has distinct absorption and emission spectra, the four nucleotides can be run in the same reaction. The analogues were also designed so that the blocking group and tags can be chemically cleaved using a palladium catalyst following each synthesis and detection step.
 
The researchers showed that DNA polymerase could incorporate the four terminator nucleotides into nascent DNA chains with high fidelity. Furthermore, they found the tagged method worked better than pyrosequencing (another SBS method) at correctly sequencing homopolymeric stretches (e.g., polyA sequences). The next step in method development, say the researchers, will be to optimize reaction conditions to extend the sequence reads from 20 nucleotides to lengths more comparable to pyrosequencing (100 nucleotides) or perhaps even Sanger sequencing (800 nucleotides).
 

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue